Disease/Infection News

RSS
Study shows peripherally inserted central catheters have similar CLABSI risk in vulnerable patients

Study shows peripherally inserted central catheters have similar CLABSI risk in vulnerable patients

Researchers improve efficacy of RASV by modifying pathogen’s ability to survive in hostile environment

Researchers improve efficacy of RASV by modifying pathogen’s ability to survive in hostile environment

Single antibiotic treatment safe and effective for children with invasive bloodstream infections

Single antibiotic treatment safe and effective for children with invasive bloodstream infections

GSK gets green light from FDA to ship Fluarix Quadrivalent influenza vaccine to healthcare providers

GSK gets green light from FDA to ship Fluarix Quadrivalent influenza vaccine to healthcare providers

Universal HIV screening in emergency department superior to testing only those with apparent risk

Universal HIV screening in emergency department superior to testing only those with apparent risk

Celiac disease patients with persistent intestine damage are at higher risk of lymphoma

Celiac disease patients with persistent intestine damage are at higher risk of lymphoma

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

Nano-machine cell killer offers new insight into fight against pathogens

Nano-machine cell killer offers new insight into fight against pathogens

Decatur Memorial Hospital installs germ-zapping robots to kill bugs

Decatur Memorial Hospital installs germ-zapping robots to kill bugs

New study paves way for novel approaches to protect people from infections

New study paves way for novel approaches to protect people from infections

China CDC, Aeras sign MOU to advance research, development of new TB vaccines

China CDC, Aeras sign MOU to advance research, development of new TB vaccines

New findings may lead to first new animal model for hepatitis C virus

New findings may lead to first new animal model for hepatitis C virus

Combating antibiotic resistance: an interview with Ron Najafi, CEO NovaBay Pharmaceuticals

Combating antibiotic resistance: an interview with Ron Najafi, CEO NovaBay Pharmaceuticals

Physicians prescribe strongest antibiotics capable of killing multiple kinds of bacteria

Physicians prescribe strongest antibiotics capable of killing multiple kinds of bacteria

FDA promise to "reboot" antibiotic development rules to combat rise in resistance falls short

FDA promise to "reboot" antibiotic development rules to combat rise in resistance falls short

Microbiologists identify staph-killing compound that may be effective for osteomyelitis

Microbiologists identify staph-killing compound that may be effective for osteomyelitis

Deletion of a protein improves ability to fight bacteria in mice with CGD

Deletion of a protein improves ability to fight bacteria in mice with CGD

LSUHSC dental school wins $1.8M grant to educate students about caring for HIV/AIDS patients

LSUHSC dental school wins $1.8M grant to educate students about caring for HIV/AIDS patients

Breath analysis: Noninvasive way to quickly determine severity of bacterial infections

Breath analysis: Noninvasive way to quickly determine severity of bacterial infections

MAPS method could speed development of new vaccines for serious pathogens

MAPS method could speed development of new vaccines for serious pathogens

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.